Posted on

Investiture: Celebration of Dr. Tansey’s appointment to the Gary D. Hughes Professorship in Pediatric Endocrinology

Dr. Tansey

In 2017, Gary D. Hughes established a philanthropic gift dedicated to finding a cure for type 1 diabetes and improving the lives of children with this disease. The gift has established the Gary D. Hughes Professorship in Pediatric Endocrinology, which is held by Michael Tansey, MD. Dr. Tansey is an ideal recipient for the Professorship, having devoted his career to the advancement of type 1 diabetes care and treatment. Having published over 60 manuscripts, primarily focused on type 1 diabetes, Dr. Tansey has contributed to knowledge about continuous glucose monitors, insulin pumps, and emerging treatments that can forestall the onset of type 1 diabetes. Today, the University honored Dr. Tansey and Gary D. Hughes for this partnership that has and will continue to benefit children with diabetes.

Posted on

New Podcast: Endocrine Disorders in Infants and Young Children

Dr. Kanner

We’re pleased to share that Dr. Kanner from our division was recently featured in a YouTube podcast hosted by pediatrician and author Dr. Carole Keim. In their 40-minute conversation, Dr. Kanner provides expert insights into a range of endocrine conditions that can affect infants and young children.

The discussion begins with congenital hypothyroidism, a serious but treatable condition that can be identified through routine newborn screening. Dr. Kanner then explores disorders related to growth abnormalities, including both insufficient and excessive growth patterns.

The conversation also covers the various forms of pediatric diabetes, highlighting key symptoms that caregivers should watch for. The episode concludes with practical advice on promoting healthy nutrition and physical activity habits in children to support long-term endocrine health.

We invite you to watch this informative and accessible interview here: the podcast on YouTube.

Thank you, Dr. Kanner, for sharing your expertise and helping to raise awareness about these important pediatric health issues.

Posted on

Announcing New Faculty: Ben Palmer, MD

Dr. Palmer

We are pleased to announce that Dr. Benjamin Palmer is starting as a new pediatric endocrinologist in our division. He received his Medical Doctorate from the University of Iowa Carver College of Medicine, completed pediatric residency at the University of Iowa Stead Family Children’s Hospital, where he also just completed fellowship in pediatric endocrinology. He has published expertise in several aspects of diabetes care in youth. His ongoing clinical interests revolve around diabetes, including diabetes and sports/exercise, and the rapidly advancing field of diabetes technology. In clinic, his initial practice will include general pediatric endocrinology and diabetes, as well as outreach services in Cedar Rapids and Dubuque. Welcome Dr. Palmer!

Posted on

Supporting Medical Student Education

Dr. Eirene Alexandrou

We are excited to announce that Dr. Alexandrou has been selected to serve as Co-Director of the Flocks Learning Community at the University of Iowa’s Carver College of Medicine. Each medical student at the Carver College of Medicine is matched into one of four Learning Communities. These Learning Communities enhance the activities and learning environment of students, in part by providing a physical study space. In her role as Co-Director, Dr. Alexandrou will provide leadership for the students in the Flocks community. She will support their support educational, philanthropic, and social endeavors in a way that extends beyond the formal medical school curriculum. Furthermore, she will provide guidance to ease transition to the rigors of medical school and give career mentorship. This is a part-time activity and Dr. Alexandrou will continue her important role as a clinical doctor providing care to children and youth with hormonal and endocrine disorders. We envision that she will provide astute and caring guidance to the Flocks Learning Community.

Posted on

Sugar Surge: Rates of Pediatric Type 2 Diabetes More than Doubled During the Pandemic

Dr. Catherina Pinnaro

Early in the pandemic, pediatric endocrinologists began noticing a rise in new cases of diabetes among youth. To investigate this trend, a group of specialists formed a national consortium representing 23 pediatric centers across the country. Their findings revealed a significant increase in new diagnoses of type 2 diabetes during the pandemic, with cases more than doubling. This increase was observed across all sampled regions of the United States. In contrast, the rise in new-onset type 1 diabetes was less pronounced and did not reach statistical significance.

Encouragingly, the number of new type 2 diabetes cases appeared to return to baseline by the end of the pandemic’s second year.

While the study was not designed to determine the exact causes of the type 2 diabetes surge, the results suggest that the major contributing factors were transient in nature. These temporary factors may have included reduced physical activity, disrupted daily routines and eating habits, and increased psychosocial stress. Perhaps less likely to play a major role would be the physiological effects of the SARS-CoV2 virus itself.

The consortium has now published these findings in the Journal of Clinical Endocrinology and Metabolism. Dr. Pinnaro, from our division, was involved with the consortium’s creation, this research and the writing of the published manuscript. The abstract can be found on PubMed at this link.

Posted on

Announcing New Pediatric Endocrine Fellow: Dr. Radig

Dr. Radig

Today we are thrilled to announce that Dr. Ashley Radig has joined our division as a new pediatric endocrine fellow. She will serve three years in this role, after which she will be a full-fledged, board-eligible pediatric endocrinologist. Dr. Radig received her Medical Doctorate degree from the University of Iowa having completed undergraduate studies at Central College where she was an athlete scholar. She just completed a three-year pediatric residency at the University of Iowa. She has a long standing interest in diabetes care and has volunteered multiple times at Diabetes Camp. In 2024, she was selected to join the PedsENDO Discovery Program administered by the Pediatric Endocrine Society. She has worked in various diabetes research programs for the past decade and has been working recently on methods to better deliver diabetes care to underserved populations. A warm welcome from all of us to Dr. Radig!!

Posted on

Dr. Palmer Completes Pediatric Endocrine Fellowship

Dr. Palmer

We are extremely proud of Dr. Ben Palmer. For the past 3 years, Dr. Palmer has been a pediatric endocrinology fellow in our program. Today he finishes this training and will officially become a “board eligible” pediatric endocrinologist. During these past three years, Dr. Palmer has been an exemplary fellow, delivering excellent clinical care and demonstrating exceptional clinical interpersonal skills and judgement. His contributions include being an enthusiastic volunteer at Diabetes Camp Hertko Hollow. While a fellow, he has been an energetic scholar, publishing two articles on how review of continuous glucose monitoring data at home impacts outcomes of type 1 diabetes in children and adolescents. His most recent work in not yet published, but involves how exercise and athletic participation is impacted by type 1 diabetes in youth. Dr. Palmer will be taking a position as a Pediatric Endocrinology attending — stay tuned for more details! Congratulations Dr. Palmer on completing fellowship!!!

Posted on

Adrenal Insufficiency after Pediatric ICU

Dr. Radig

Children admitted to the Pediatric Intensive Care Unit (PICU) often receive glucocorticoid steroids as part of their treatment. While these medications can be highly effective in managing critical illness, prolonged use may lead to adrenal insufficiency—a dangerous but treatable condition in which the body cannot produce adequate levels of cortisol. To better understand the risks, researchers reviewed the medical records of 530 pediatric patients who received steroids during their PICU stay. Among these patients, 2.3% were diagnosed with adrenal insufficiency. The study identified several key risk factors including the following: younger age, higher cumulative dose of steroids and the use of steroids specifically for treating excess inflammation. These findings aim to improve the identification of pediatric patients at risk for adrenal insufficiency following critical illness. The study has been published in the Journal of Intensive Care Medicine. The lead author, Dr. Radig, will soon join our Division as a pediatric endocrinology fellow. Also contributing to the the research was Dr. Curtis, also from our Division. The abstract is available on PubMed at the following link.

Posted on

Dr. Castano Leads Webinar for Medical Students

Dr. Castaño

On June 10th, Dr. Castano from our division lead a live, national, free Webinar for medical students across the country. The title of his webinar was “Growth and Puberty”. His purpose was to elevate the clinical knowledge of medical students on this important topic. The session was sponsored by the Pediatric Endocrine Society. Dr. Castano covered a range of important topics ranging from normal growth patterns in children and adolescent, to various medical disorders that disrupt puberty and growth. Thank you Dr. Castano for lending your expertise to help teach tomorrow’s physicians about these important topics.

Posted on

Long-Term Study Links Elevated Glucose Levels to Persistent Brain Changes in Children with Type 1 Diabetes

Dr. Tsalikian
Dr. Tansey

In 2018, faculty from our division participated in a multicenter, observational study that added to growing evidence linking elevated glucose levels in children with type 1 diabetes to changes in brain structure. While the initial findings highlighted these associations, they could not determine how such changes might evolve over time. Now, the research team—including Drs. Tsalikian and Tansey from our division—has completed a long-term follow-up of the original study participants. The results, recently published in the journal Diabetes, are available via PubMed (link here) in abstract form. The follow-up spanned 6 to 8 years and revealed that the previously observed brain differences largely persisted. Although the magnitude of some differences diminished slightly, higher average blood glucose levels continued to correlate with more pronounced structural changes. These findings reinforce the importance of maintaining tight glycemic control to potentially mitigate long-term neurological impacts. As the cohort transitions into adulthood, continued monitoring will be essential to fully understand the long-term implications of these early brain changes.